drugset / Trial / NCT01289639

Insulin Resistance in Non-alcoholic Fatty Liver Disease

NCT01289639

Terminated 11 enrolled VA Office of Research and Development
RandomizedParallel-groupDouble-blindBasic science

Summary

The study is designed to investigate the relationship between insulin resistance and non-alcoholic fatty liver disease (NAFLD) and to investigate potential mechanisms underlying insulin resistance in NAFLD by determining associations between hepatic and peripheral insulin sensitivity, hepatic steatosis, dyslipidemia, inflammatory cytokines, glucose metabolism, beta-cell function and body fat distribution.

Timeline

Start
2005-10
Primary completion
2013-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 200 mg Oral
Subject Pioglitazone Small molecule 30 mg Oral

Indications